ACADI highlighted in Parliamentary Report
The final report from the Parliamentary Inquiry into Diabetes has been released with 23 recommendations, many of which were advocated by The Australian Centre for Accelerating Diabetes Innovations (ACADI).
Notably, the inquiry has endorsed the broader availability of subsidised Continuous Glucose Monitors and insulin pumps for patients with both Type 1 and Type 2 diabetes – which are important areas of research and advocacy for ACADI.
ACADI Director and Head of the Department of Medicine, Professor Elif Ekinci, presented to the Inquiry in Canberra during its hearings in March 2024 alongside Ray Kelly (Gomeroi man, ACADI PhD student and researcher and MRFF grantee) and Naomi Hodgson (Barrister and ACADI Council member). Pleasingly, ACADI’s written and verbal submissions were quoted multiple times throughout the report, demonstrating the important role researchers have in also advocating for policy change.
“This is what ACADI does—we play a significant leadership role in the production of life-changing and often life-saving translational research and contribute to the broader Australian policy landscape.”—Professor Elif Ekinci.
Improving health equity is also a critical focus of the report. It includes recommendations for improving access to diabetes care and support in high-risk rural and remote communities, particularly for First Nations peoples. ACADI investigators are conducting the first Australian research clinical trial for diabetes technology for First Nations people in rural and remote Australia, researching the impact of diabetes technology on the management of type 2 diabetes.
